A practical reference on PPARδ agonist: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-03-18. Anything still debated is marked as such rather than presented as settled.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Typical form of reference material |
| Solubility | Low in water; soluble in DMSO | Used to prepare stock solutions |
| Typical storage | -20 °C, desiccated, protected from light | Common laboratory practice |
| Analytical method | LC-MS/MS | Detects parent compound and metabolites |
| Common test matrix | Urine or blood | Used in anti-doping analysis |
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
acylation The covalent attachment of any acyl group (e.g. acetyl or benzoyl) to a chemical compound, protein, or other biomolecule via the substitution of the acyl group for a hydrogen atom, either spontaneously or by enzymatic catalysis. Acetylation is a type of acylation.
If equal quantities of NaOH and HCl are dissolved, the base and the acid neutralize exactly, leaving only NaCl, effectively table salt, in solution. Weak bases, such as baking soda or egg white, should be used to neutralize any acid spills. Neutralizing acid spills with strong bases, such as sodium hydroxide or potassium hydroxide, can cause a violent exothermic reaction, and the base itself can cause just as much damage as the original acid spill.
Similarly to the findings with a strong CYP2D6 inhibitor, a pharmacogenomic clinical study with LSD found that LSD levels were 75% higher in people with non-functional CYP2D6 (poor metabolizers) compared to those with functional CYP2D6. Serotonin syndrome can be caused by combining psychedelics with other serotonergic drugs, including certain antidepressants, opioids, psychostimulants (e.g. MDMA), serotonin 5-HT1 receptor agonists (e.g. triptans), herbs or supplements, and others. However, there is said to be no risk of serotonin syndrome when psychedelics like LSD or psilocybin are taken while on SSRIs. The same is not true of ayahuasca, as ayahuasca also contains harmala alkaloids which act as MAOIs and can produce life-threatening serotonin toxicity when combined with SSRIs. A high rate of seizures has been reported when people on lithium have taken serotonergic psychedelics. In an analysis of online reports, 47% of 62 accounts reported seizures when a psychedelic was taken while on lithium. The mechanism of this interaction is unclear.
Sources: en.wikipedia.org
== Personal life == Dustin's son Mason is the former punter for the University of Cincinnati Bearcats in American football. Dustin's son Max is the current punter for the University of Cincinnati Bearcats and formerly played at the University of Arkansas. In Mason's freshman (first) season in 2021, the Bearcats became the first-ever team from a Group of Five conference to reach the College Football Playoff. Mason's sophomore season in 2022, the Bearcats' last before joining the Power Five Big 12 Conference, saw him named the special teams player of the year in the American Athletic Conference.
=== Religion === Head-shaving (tonsure) is a part of some Buddhist, Christian, Muslim, Jain and Hindu traditions. Buddhist and Christian monks generally undergo some form of tonsure during their induction into monastic life. Within Amish society, tradition ordains men to stop shaving a part of their facial hair upon marriage and grow a Shenandoah style beard which serves the significance of wearing a wedding ring; moustaches are rejected as they are regarded as martial (traditionally associated with the military). In Judaism (see Shaving in Judaism), there is no obligation for women to remove body hair or facial hair, unless they wish to do so. However, in preparation for a woman's immersion in a ritual bath after concluding her days of purification (following her menstrual cycle), the custom of Jewish women is to shave off their pubic hair. During a mourning ritual, Jewish men are restricted in the Torah and Halakha to using scissors and prohibited from using a razor blade to shave their beards or sideburns, and, by custom, neither men nor women may cut or shave their hair during the shiva period. The Baháʼí Faith recommends against complete and long-term head-shaving outside of medical purposes. It is not currently practiced as a law, contingent upon a future decision by the Universal House of Justice, its highest governing body. Sikhs take an even stronger stance, opposing all forms of hair removal. One of the "Five Ks" of Sikhism is Kesh, meaning "hair".
The widespread nature of Gulf of Mexico chemosynthetic communities was first documented during contracted investigations by the Geological and Environmental Research Group (GERG) of Texas A&M University for the Offshore Operators Committee. This survey remains the most widespread and comprehensive, although numerous additional communities have been documented since that time. Industry exploration for energy reserves in the Gulf of Mexico has also documented numerous new communities through a wide range of depths, including the deepest-known occurrence in the Central Gulf of Mexico in Alaminos Canyon Block 818 at a depth of 2,750 metres (9,020 feet). The occurrence of chemosynthetic organisms dependent on hydrocarbon seepage has been documented in water depths as shallow as 290 metres (950 feet) and as deep as 2,744 metres (9,003 feet). This depth range specifically places chemosynthetic communities in the deepwater region of the Gulf of Mexico, which is defined as water depths greater than 305 metres (1,001 feet). Chemosynthetic communities are not found on the continental shelf, although they do appear in the fossil record in water shallower than 200 metres (660 feet). One theory explaining this is that predation pressure has varied substantially over the time period involved (Callender and Powell 1999). More than 50 communities are now known to exist in 43 Outer Continental Shelf (OCS) blocks.
Sources: en.wikipedia.org
Anti-doping and clinical laboratories commonly use liquid chromatography-tandem mass spectrometry. The method can identify GW501516 and its metabolites in urine or blood. Detection depends on sample timing and the amount present.
PPARδ is a nuclear receptor that regulates genes linked to fatty acid oxidation and energy metabolism. Activation can alter lipid handling and energy use in experimental models. The full range of effects in humans is still under study.
The solid compound is generally stable when kept cold, dry, and protected from light. Solutions may degrade faster, so laboratory protocols often specify fresh preparation or cold storage. Stability can depend on solvent, concentration, and container.
It binds and activates PPARδ, a nuclear receptor that influences gene expression related to fatty acid metabolism and energy balance. This mechanism has been studied mainly in animals and cell models, not established as a safe human therapy.